Servier in the U.S. is a Boston-based, commercial-stage biopharmaceutical company launched by Servier Group in 2018. As a privately held organization, Servier is uniquely positioned to advance cutting-edge science, tackle underserved therapeutic areas and make patients the focus of every strategic decision. Our pipeline is promising in Oncology and Neurology, and following the acquisition of Sevasemten for Becker Muscular Dystrophy (BMD) and Duchenne Muscular Dystrophy (DMD), we are at the very beginning of building out our US Neurology franchise and preparing for our first launch in Neurology.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level